Prospective study of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer without pathologic confirmatio
Phase 2
- Conditions
- primary lung cancer
- Registration Number
- JPRN-UMIN000002458
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
With a median follow-up period of 55 months, the 3-year overall survival rate was 83% (95%CI:71-91%). Grade 3 and 4 chronic adverse event was experienced in 8 and 1 patients, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1) Apparent interstitial pneumonia on chest X-ray. 2) Patinets with active infectious disease. 3) Patients with active other cancers. 4) Pregnant patients. 5) Patients with psychiatric disorders and unable to participate the study. 6) Patients now treated by steroids. 7) Patients who need oxygen inhalation. 8) Fever up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method